Fed. Circ. Revives Teva's Suit Over Aricept Patents
A federal appeals court has revived Teva Pharmaceuticals USA Inc.'s effort to get a declaratory judgment on Eisai Co. Ltd.'s patents for Aricept so the generics maker can get approval for...To view the full article, register now.
Already a subscriber? Click here to view full article